+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Organ Preservation Market 2019-2025

  • ID: 4896936
  • Report
  • October 2019
  • Region: Global
  • Orion Market Research Private Limited


  • Biolife Solutions, Inc.
  • Biotime, Inc.
  • Bridge to Life, Ltd.
  • CryoLife, Inc.
  • Lifeline Scientific, Inc.
  • Organ Recovery Systems
The global organ prevention market is expected to grow at a significant CAGR of 7.2% during the forecast period. Organ preservation systems are designed according to the requirement of specific organs and are maintained to meet the biological conditions such as temperature and oxygen to store an organ. The government around the globe takes initiatives to encourage organ transplantation among the population which in turn is supporting the organ preservation industry. For instance, in Japan, there is organ transplantation that legalized organ procurement from the brain dead and non-heart beating donors. There was a total of 97 donors during 2018.

The global organ preservation market is segmented on the basis of technique and organ type. Based on the technique, the market is segmented into cold storage (SCS) technique and dynamic cold storage (DCS). The dynamic cold storage is further segmented into normothermic machine perfusion, hypothermic machine perfusion, and oxygen insufflation. Further, on the basis of organ type, the market is segmented into kidney, liver, lung, heart, other organs such as pancreas and intestine. Geographically, the market is segmented into four major regions; North America, Europe, Asia-Pacific and the Rest of the world (RoW).

North America is expected to hold a significant share in the market owing to the rising number of organ transplantation procedures and the growing awareness regarding organ preservation and growing technological advancement. Some of the major players operating in the global organ preservation market include Organ Recovery Systems, CryoLife Inc., Lifeline Scientific Inc., BioLife Solutions Inc., XVIVO Perfusion and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition, and product launch to strengthen their presence in the global market.

Research Methodology

The market study of the organ preservation market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary sources include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for organ preservation solutions and device providers, life sciences companies, medical, device manufacturers, market research and consulting firms, healthcare service providers, medical, research institutes, regulatory bodies and venture capitalists for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Organ Preservation Market Research and Analysis by Solution
2. Global Organ Preservation Market Research and Analysis by Technique
3. Global Organ Preservation Market Research and Analysis by Organ Type.

The Report covers:
  • Comprehensive research methodology of the global organ preservation market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global organ preservation market.
  • Insights about market determinants which are stimulating the global organ preservation market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown


  • Biolife Solutions, Inc.
  • Biotime, Inc.
  • Bridge to Life, Ltd.
  • CryoLife, Inc.
  • Lifeline Scientific, Inc.
  • Organ Recovery Systems
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Organ Preservation Market by Technique
5.1.1. Static Cold Storage (SCS) Technique
5.1.2. Dynamic Cold Storage (DCS) Technique
5.2. Global Organ Preservation Market by Organ Type
5.2.1. Kidney
5.2.2. Liver
5.2.3. Lung
5.2.4. Heart
5.2.5. Other Organs (Pancreas, Intestine)

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. 21st Century Medicine, Inc.
7.2. Biolife Solutions, Inc.
7.3. Biotime, Inc.
7.4. Bridge to Life, Ltd.
7.5. CryoLife, Inc.
7.6. Essential Pharmaceuticals, LLC
7.7. Lifeline Scientific, Inc.
7.8. Organ Assist Products B.V.
7.9. Organ Recovery Systems
7.10. OrganOx, Ltd.
7.11. Paragonix Technologies, Inc.
7.12. Preservation Solutions, Inc.
7.13. TransMedics, Inc.
7.14. Waters Medical Systems, LLC
7.15. XVIVO Perfusion
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 21st Century Medicine, Inc.
  • Biolife Solutions, Inc.
  • Biotime, Inc.
  • Bridge to Life, Ltd.
  • CryoLife, Inc.
  • Essential Pharmaceuticals, LLC
  • Lifeline Scientific, Inc.
  • Organ Assist Products B.V.
  • Organ Recovery Systems
  • OrganOx, Ltd.
  • Paragonix Technologies, Inc.
  • Preservation Solutions, Inc.
  • TransMedics, Inc.
  • Waters Medical Systems, LLC
  • XVIVO Perfusion
Note: Product cover images may vary from those shown